Medical Services International to Supply VScan Test Kits for Private Testing
January 12 2006 - 6:00AM
PR Newswire (US)
EDMONTON, Alberta, Jan. 12 /PRNewswire-FirstCall/ -- Medical
Services International Services Inc. (OTC:MSITF) is pleased to
announce that it has been asked to supply test kits to a private
hospital in Anhui Province in China. This hospital does annual
testing of employees for a steel processing company in Anhui
Province. The Chinese company employs in excess of 300,000 people
and requires that the employees be tested yearly for HIV, Hepatitis
C and Tuberculosis (TB). Medical Services has also been asked to
supply test kits for STDs which includes syphilis for which there
is a VScan test kit. There are several other test kits being
requested that Medical Services will be able to supply. The Company
anticipates that between the VScan kits that will be used as well
as the other kits required that this contract should generate
revenue of $1.3 to $1.5 million US per year. This will also allow
our other sales networks in China to contact other large Chinese
corporations and offer the same testing program. About VScan The
VScan rapid test kit is a single use, disposable, accurate, cost
effective, easy to use, test for the screening of HIV 1&2,
Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile,
Syphilis, Malaria and Prostate Cancer. The kits cannot be sold in
Canada. Medical Services International Inc. trades in the United
States on the NQB Pinksheets under the symbol "MSITF". For further
information, please contact Robert Talbot at (780) 430 6363 or
media contact Bill Whitehead at (416) 822 5883 or
http://www.medicalservicesintl.com/ or
http://www.minerva-biotech.com/ . NOTE: Certain statements in this
press release are "forward-looking statements" within the meaning
of the Private Securities Act of 1995. Such statements involve
known and unknown risks, uncertainties and other factors that may
cause results to differ materially. Such risks, uncertainties and
other factors include but are not limited to new economic
conditions, risk in product development, market acceptance of new
products and continuing product demand, level of competition and
other factors described in Company reports and other filings with
regulatory bodies. Medical Services International Inc. DATASOURCE:
Medical Services International Inc. CONTACT: Robert Talbot,
+1-780-430-6363, or Bill Whitehead, +1-416-822-5883, both for
Medical Services International Inc. Web site:
http://www.medicalservicesintl.com/ http://www.minerva-biotech.com/
Copyright